Product Details:
| Product Type | capsules |
| Drug Name | ceritinib |
| Dose Strength | 150mg |
| Type | Allopathic |
| Packaging Type | 3 Bottles |
| Packaging Size | 150 |
| Gender | Unisex |
| Certification | FDA |
| Storage Condition | room temprature |
| No of tablets | 150 |
| Form | capsules |
Additional Information:
Product Details:
| Brand | Noxalk |
| Packaging Type | Bottle |
| Composition | Ceritinib |
| Drug Name | Ceritinib |
| Dose/Strength | 150mg |
| Dosage Form | Capsules |
| Form of Medicine | Capsule |
| Quantity Per Pack | 1*30 |
| No of tablets | 30 |
Generic Content- Ceritinib, Manufactured By: Natco,India
Ceritinib is a prescription-only drug used for the treatment non-small cell lung cancer. It was developed by Novartis and received FDA approval for use in April 2014. It is available as a 150 mg capsule with a one-time daily dosing requirement of 750 mg for NSCLC.